To further investigate the clinical significance of ACSL4 and CD8+ T cell infiltration, we explored the associations between ACSL4 and CD8A expression and expression of immune checkpoint genes, which are important markers for BLCA immunotherapy responses. This evidence concerns the gene CD8A and bladder transitional cell carcinoma.